HYMPAVZI is a once-weekly subcutaneous treatment option for individuals with severe haemophilia A or B. Credit: ...

Technology has changed the clinical trial landscape forever, with application programming interfaces (APIs) growing in ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

Events like the RFK Jr nomination as US HHS head, Labour’s 10-year plan, and centralised EU funding will steer the sector’s ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

The companies have teamed up to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell ...

Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to ...

TV personality Dr Oz has been nominated by President-elect Donald Trump to lead the Centers for Medicare and Medicaid ...

UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare ...

Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab for malignant ascites.

The US FDA has issued a CRL for sNDA of Astellas Pharma’s IZERVAY, a treatment for geographic atrophy (GA) secondary to AMD.